How Decentralized AI is Unlocking Value in Cardiac Diagnostics

Executive Summary

• VentriPoint Diagnostics announced a partnership with First Light Health to deliver AI‑powered cardiac diagnostics to Indigenous and remote communities across Canada, using its VMS+™ system in a hub‑and‑spoke model.
• The company also disclosed recent commercial agreements with LG Consulting Solutions for deployment in Northern California and an earlier pilot with the Nisga’a Valley Health Authority in northern BC.
• The release situates VentriPoint’s expansion within broader industry trends, citing AI adoption in cardiovascular diagnostics and highlighting comparable initiatives by peers (HeartBeam, Heartflow, Hyperfine, GE Healthcare).

Key Details

• Partnership Scope: First Light Health will act as the local provider; remote clinics capture 2‑D echocardiograms that are transmitted to a central hub where specialists interpret images using VentriPoint’s VMS+™ AI platform.
• Geographic Reach: Initial rollout targets British Columbia, Yukon, Alberta, Manitoba and New Brunswick, with plans to scale nationally and eventually to underserved regions worldwide (e.g., Arctic, Amazon).
• Technology Claim: VMS+™ converts standard 2‑D ultrasound into 3‑D volumetric images with accuracy “comparable to cardiac MRI” at lower cost and without the need for MRI infrastructure.
• Commercial Agreements:
• Signed a commercial agreement with LG Consulting Solutions to support VMS+™ deployment across cardiac centres in Sacramento and San Francisco, California.
• Previously partnered with Nisga’a Valley Health Authority to pilot the same hub‑and‑spoke model in northern BC.
• Regulatory Status: VentriPoint holds regulatory approvals for its platform in the United States, Canada, and Europe.
• Industry Context (provided for background):
• FDA registry now exceeds 1,200 approved AI medical devices; cardiovascular applications are the second‑largest category.
• EU healthcare spending on heart disease > €282 billion annually; 1.7 million deaths per year.
• Peer companies announced related AI collaborations and clinical data (HeartBeam–Mount Sinai AI‑ECG, Heartflow plaque registry, Hyperfine portable MRI stroke study, GE Healthcare COMPASS consortium).

Notable Quotes

• “Cardiovascular disease doesn't respect geography, but too often, access to cardiac care does,” – Hugh MacNaught, CEO, VentriPoint Diagnostics.
• “Our work with First Light Health and other First Nations partners demonstrates the need for a made‑in‑Canada innovation that can close that gap.” – Hugh MacNaught.